St. Erik Eye Hospital
14
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
21.4%
3 terminated/withdrawn out of 14 trials
66.7%
-19.8% vs industry average
21%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients
Role: collaborator
Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD
Role: lead
Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
Role: lead
Modification of Scleral Suture Fixation of Dislocated IOL
Role: lead
The Avastin vs Visudyne for Neovascular AMD Study
Role: lead
Impact of Self-tonometry on Glaucoma Treatment Decision.
Role: lead
iCare® Home vs Goldmann Applanation Tonometry
Role: lead
Antisecretory Factor (AF) Effects on Intraocular-pressure
Role: lead
IOP Monitoring After Trabeculectomy Using iCare Home
Role: lead
Monitoring of the IOP After SLT Using iCare Home
Role: lead
Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension
Role: lead
The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo
Role: lead
Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled Study
Role: lead
TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
Role: lead
All 14 trials loaded